Toxicity fluoroquinolone use outweighs the risk fluoroquinolones. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Organisms27

Pseudomonas aeruginosa Staphylococcus aureus Escherichia coli Streptococcus pneumoniae Gram-Negative Bacteria Gram-Positive Bacteria Mycoplasma hominis Mycobacterium tuberculosis Clostridium difficile Neisseria gonorrhoeae Salmonella typhi Salmonella enterica Mycobacterium fortuitum Bacteria, Anaerobic Klebsiella pneumoniae Bacteria Salmonella paratyphi A Campylobacter jejuni Campylobacter Enterobacteriaceae Gram-Positive Cocci Campylobacter coli Moraxella (Branhamella) catarrhalis Mycobacterium smegmatis Bacteroides fragilis Enterococcus faecalis Acinetobacter

Diseases27

Escherichia coli Infections Pseudomonas Infections Staphylococcal Infections Cross Infection Dermatitis, Phototoxic Gram-Negative Bacterial Infections Pneumococcal Infections Bacterial Infections Urinary Tract Infections Community-Acquired Infections Typhoid Fever Eye Infections, Bacterial Tuberculosis, Multidrug-Resistant Dermatitis, Photoallergic Gonorrhea Paratyphoid Fever Campylobacter Infections Respiratory Tract Infections Gram-Positive Bacterial Infections Enterocolitis, Pseudomembranous Salmonella Infections Bacteremia Extensively Drug-Resistant Tuberculosis Klebsiella Infections Pneumonia, Bacterial Bronchitis, Chronic Tuberculosis

Chemicals and Drugs45

Fluoroquinolones Anti-Infective Agents Ciprofloxacin Anti-Bacterial Agents DNA Gyrase Ofloxacin DNA Topoisomerase IV Aza Compounds Levofloxacin Quinolones Norfloxacin Naphthyridines Pefloxacin Quinolines Enoxacin DNA Topoisomerases, Type II 4-Quinolones Nalidixic Acid Topoisomerase II Inhibitors DNA, Bacterial Fleroxacin Macrolides Antitubercular Agents Bacterial Proteins beta-Lactams DNA Topoisomerases Aminoglycosides Anti-Infective Agents, Urinary Dioxolanes Cephalosporins Membrane Transport Proteins beta-Lactamases Erythromycin Reserpine Nitrofurantoin Trimethoprim-Sulfamethoxazole Combination Ethambutol Lactams Multidrug Resistance-Associated Proteins Capreomycin Streptogramin B Carbapenems Piperazines Ethidium Rifampin

Analytical, Diagnostic and Therapeutic Techniques and Equipment15

Microbial Sensitivity Tests Toxicity Tests Area Under Curve Toxicity Tests, Acute Electrophoresis, Gel, Pulsed-Field Administration, Oral Sequence Analysis, DNA Colony Count, Microbial Amino Acid Substitution Polymerase Chain Reaction Treatment Outcome Ribotyping Disk Diffusion Antimicrobial Tests Antibiotic Prophylaxis Drug Therapy, Combination

Phenomena and Processes15

Drug Resistance, Bacterial Drug Resistance, Multiple, Bacterial Drug Resistance, Microbial Methicillin Resistance Mutation Drug Resistance, Multiple Area Under Curve Dose-Response Relationship, Drug Genes, Bacterial Drug Interactions Amino Acid Substitution beta-Lactam Resistance Time Factors Cephalosporin Resistance Plasmids

Information Science1

Molecular Sequence Data

Health Care4

Drug Utilization Hospitals Area Under Curve Treatment Outcome

Geographicals1

Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care Geographicals

Fluoroquinolones Anti-Infective Agents Ciprofloxacin Drug Resistance, Bacterial Anti-Bacterial Agents DNA Gyrase Microbial Sensitivity Tests Ofloxacin Drug Utilization DNA Topoisomerase IV Aza Compounds Levofloxacin Quinolones Norfloxacin Drug Resistance, Multiple, Bacterial Naphthyridines Escherichia coli Infections Pefloxacin Hospitals Quinolines Pseudomonas Infections Pseudomonas aeruginosa Drug Resistance, Microbial Staphylococcus aureus Staphylococcal Infections Enoxacin DNA Topoisomerases, Type II Escherichia coli 4-Quinolones Cross Infection Streptococcus pneumoniae Nalidixic Acid Methicillin Resistance Dermatitis, Phototoxic United States Topoisomerase II Inhibitors Mutation Gram-Negative Bacteria DNA, Bacterial Fleroxacin Macrolides Antitubercular Agents Gram-Positive Bacteria Gram-Negative Bacterial Infections Toxicity Tests Pneumococcal Infections Bacterial Infections Bacterial Proteins Mycoplasma hominis beta-Lactams DNA Topoisomerases Mycobacterium tuberculosis Urinary Tract Infections Community-Acquired Infections Drug Resistance, Multiple Clostridium difficile Typhoid Fever Eye Infections, Bacterial Aminoglycosides Neisseria gonorrhoeae Salmonella typhi Area Under Curve Tuberculosis, Multidrug-Resistant Salmonella enterica Mycobacterium fortuitum Dermatitis, Photoallergic Bacteria, Anaerobic Anti-Infective Agents, Urinary Klebsiella pneumoniae Gonorrhea Dioxolanes Bacteria Dose-Response Relationship, Drug Genes, Bacterial Salmonella paratyphi A Paratyphoid Fever Campylobacter jejuni Campylobacter Infections Cephalosporins Membrane Transport Proteins Toxicity Tests, Acute Respiratory Tract Infections beta-Lactamases Electrophoresis, Gel, Pulsed-Field Campylobacter Gram-Positive Bacterial Infections Enterocolitis, Pseudomembranous Salmonella Infections Administration, Oral Enterobacteriaceae Gram-Positive Cocci Sequence Analysis, DNA Campylobacter coli Erythromycin Bacteremia Colony Count, Microbial Drug Interactions Reserpine Nitrofurantoin Extensively Drug-Resistant Tuberculosis

No FAQ available that match "toxicity fluoroquinolone use outweighs the risk fluoroquinolones"